Preparation and in-vitro evaluation of pegylated plga nanoparticles of meloxicam

• In: Industrial Pharmacy Posters
• At: Lisbon (Portugal) (2010)
• Type: Poster
• Poster code: IPS-P-036
• By: HASCICEK, Canan (Ankara Univercity, Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey)
• Co-author(s): Sengel-Türk, C.Tuba (Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Technology, ANKARA, Turkey)
  Hascicek, Canan (Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Technology, ANKARA, Turkey)
  Gönül, Nursin (Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Technology, ANKARA, Turkey)
  Dogan, Lale (Hacettepe University, Oncology Institute, Department of Basic Oncology, ANKARA, Turkey)
  Guc, Dicle (Hacettepe University, Oncology Institute, Department of Basic Oncology, ANKARA, Turkey)
  
• Abstract:

  Recently, continuous usage of cyclooxygenase (COX)-2 inhibitors such as meloxicam have been reported to decrease the relative risk of colon cancer significantly. Nanoparticle (NP) formulations of anticancer drugs have become an important research area. Several methods such as PEGylation were used for the surface modifications of NPs to improve..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login